{{Rsnum
|rsid=883484
|Chromosome=9
|position=122362748
|Orientation=minus
|GMAF=0.2668
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 17.8 | 51.1 | 31.1
| JPT | 18.2 | 45.5 | 36.4
| YRI | 1.6 | 23.8 | 74.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 17.8 | 51.1 | 31.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19282863
|Title=Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension
}}

{{PMID|19091535}} A polymorphism in the cyclooxygenase 1 gene is associated with decreased inflammatory prostaglandin F2alpha formation and lower risk of cardiovascular disease.

{{PMID|19406964|OA=1
}} Association of genetic variants with chronic kidney disease in Japanese individuals.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}